Item 1. Financial Statements
ITEM 1. FINANCIAL STATEMENTS (Unaudited)
EQUATOR BEVERAGE COMPANY
Condensed Balance Sheets (Unaudited)
As of September 30, 2023 and December 31, 2022
September 30,
2023
December 31,
2022
ASSETS
CURRENT ASSETS:
Cash and cash equivalents
$ 330
$ 10,738
Accounts receivable, net
247,462
93,852
Inventory
233,343
268,289
Supplier deposits
23,600
44,772
Prepaid expenses
40,044
23,468
Total Current Assets
$ 544,779
$ 441,119
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES:
Accounts payable and accrued expenses
$ 68,943
$ 70,252
Related party loans
240,000
225,000
Total Current Liabilities
308,943
295,252
STOCKHOLDERS’ EQUITY
Common stock, 20,000,000 shares authorized at $ 0.001 par value, 16,641,096 and 16,230,615 shares issued and outstanding, at September 30, 2023 and December 31, 2022, respectively
16,641
16,231
Additional paid-in capital
23,879,072
23,758,917
Accumulated deficit
( 23,659,877 )
( 23,629,281 )
Total Stockholders’ Equity
235,836
145,867
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY
$ 544,779
$ 441,119
The accompanying notes are an integral part of these condensed financial statements.
F-1
Table of Contents
EQUATOR BEVERAGE COMPANY
Condensed Statements of Operations (Unaudited)
For the Three Months Ended September 30, 2023 and 2022
2023
2022
Revenue
$ 675,947
$ 548,973
Cost of Revenue
367,262
380,864
Gross Profit
308,685
168,109
Operating Expenses
Selling, general and administrative
358,639
198,122
Total Operating Expenses
358,639
198,122
Loss from Operations
( 49,954 )
( 30,013 )
Interest Expense
( 3,957 )
( 3,335 )
Net Loss
$ ( 53,911 )
$ ( 33,348 )
Net Loss per common share, basic and diluted
$ 0.00
$ 0.00
Weighted average number of common shares outstanding, basic and diluted
17,274,826
16,092,401
The accompanying notes are an integral part of these condensed financial statements.
F-2
Table of Contents
EQUATOR BEVERAGE COMPANY
Condensed Statements of Operations (Unaudited)
For the Nine Months Ended September 30, 2023 and 2022
2023
2022
Revenue
$ 1,780,059
$ 1,469,732
Cost of Revenue
988,441
966,207
Gross Profit
791,618
503,525
Operating Expenses
Selling, general and administrative
812,222
667,918
Total Operating Expenses
812,222
667,918
Loss from Operations
( 20,604 )
( 164,393 )
Interest Expense
( 9,992 )
( 7,161 )
Loss Before Provision for Income Taxes
( 30,596 )
( 171,554 )
Provision for Income Taxes
-
-
Net Loss
$ ( 30,596 )
$ ( 171,554 )
Net Loss per common share, basic and diluted
$ 0.00
$ ( 0.01 )
Weighted average number of common shares outstanding, basic and diluted
16,582,510
15,732,060
The accompanying notes are an integral part of these condensed financial statements.
F-3
Table of Contents
EQUATOR BEVERAGE COMPANY
Condensed Statements of Cash Flows (Unaudited)
For the Nine Months Ended September 30, 2023 and 2022
2023
2022
Cash flows from operating activities:
Net loss
$ ( 30,596 )
$ ( 171,554 )
Adjustments to reconcile net loss to net cash provided by/ (used in) operating activities:
Stock issued to directors and employees
158,567
159,923
Changes in assets and liabilities:
Increase in accounts receivable
( 153,610 )
( 148,044 )
Decrease/(Increase) in inventory
34,946
( 16,244 )
Decrease/(Increase) in supplier deposits
21,172
( 1,850 )
Increase in prepaid expenses
( 16,576 )
( 20,564 )
(Increase)/Decrease in accounts payable and accrued expenses
( 1,309 )
54,214
Net cash provided by / (used in) operating activities
12,594
( 144,119 )
Net cash provided by/ (used in) financing activities:
Proceeds from related party loan
170,000
295,000
Repayments of related party loan
( 155,000 )
( 20,000 )
Proceeds from options exercise
-
25,448
Shares repurchased for cancellation
( 38,002 )
( 193,188 )
Net cash (used in) / provided by financing activities
( 23,002 )
107,260
Net increase/ (decrease) in cash and cash equivalents
( 10,408 )
( 36,859 )
Cash and cash equivalents at beginning of period
10,738
46,481
Cash and cash equivalents at end of periods
$ 330
$ 9,622
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash Paid for Interest
$ 9,992
$ 7,161
Summary of non-cash investing and financing activity: During the nine-month period ended September 30, 2023 the Company issued a total of 790,500 Restricted and Non-Trading shares with an implied value of $158,567 to directors and officers as a result of contractual stock awards. During the nine-month period ended September 30, 2022 the Company issued a total of 1,198,554 Restricted and Non-Trading shares with an implied value of $184,408 to directors and officers as a result of contractual stock awards and to settle obligations payable.
The accompanying notes are an integral part of these condensed financial statements.
F-4
Table of Contents
EQUATOR BEVERAGE COMPANY
Condensed Statements of Changes in Stockholders’ Equity (Unaudited)
For the Nine Months Ended September 30, 2023 and 2022
Common Stock
Additional
Paid-In
Accumulated
Stockholders’
Shares
Amount
Capital
Deficit
Equity
Balance, December 31, 2022
16,230,615
$ 16,231
$ 23,758,917
$ ( 23,629,281 )
$ 145,867
Stock issued to Directors and employees
238,500
238
13,754
-
13,992
Stock repurchased and returned to Treasury
-
-
-
-
-
Net Income
-
-
-
4,485
4,485
Balance, March 31, 2023
16,469,115
$ 16,469
$ 23,772,671
$ ( 23,624,796 )
$ 164,344
Stock issued to Directors and employees
238,500
239
25,996
-
26,235
Stock repurchased and returned to Treasury
( 380,019 )
( 380 )
( 37,622 )
-
( 38,002 )
Net Income
-
-
-
18,830
18,830
Balance, June 30, 2023
16,327,596
$ 16,328
$ 23,761,045
$ ( 23,605,966 )
$ 171,407
Stock issued to Directors and employees
313,500
313
118,027
118,340
Net Loss
( 53,911 )
( 53,911 )
Balance, September 30, 2023
16,641,096
$ 16,641
23,879,072
( 23,659,877 )
235,836
Common Stock
Additional
Paid-In
Accumulated
Total
Shares
Amount
Capital
Deficit
Balance, December 31, 2021
15,548,903
$ 15,549
$ 23,745,449
$ ( 23,390,445 )
$ 370,553
Stock issued to Directors and employees
681,750
682
111,323
-
112,005
Stock repurchased and returned to Treasury
( 375,000 )
( 375 )
( 100,875 )
-
( 101,250 )
Net loss
-
-
-
( 135,379 )
( 135,379 )
Balance, March 31, 2022
15,855,653
$ 15,856
$ 23,755,897
$ ( 23,525,824 )
$ 245,929
Stock issued to Directors and employees
119,250
119
23,949
-
24,068
Exercise of Stock Options
159,054
159
25,289
-
25,448
Stock repurchased and returned to Treasury
( 455,342 )
( 455 )
( 91,483 )
-
( 91,938 )
Net Loss
-
-
-
( 2,827 )
( 2,827 )
Balance, June 30, 2022
15,678,615
$ 15,679
$ 23,713,652
$ 23,528,651
$ 200,680
Stock issued to Directors and employees
238,500
239
23,611
23,850
Net Loss
( 33,348 )
( 33,348 )
Balance, September 30, 2022
15,917,115
15,918
23,737,263
( 23,561,999 )
191,182
The accompanying notes are an integral part of these condensed financial statements.
F-5
Table of Contents
EQUATOR BEVERAGE COMPANY
Notes to Condensed Financial Statements (Unaudited)
September 30, 2023
NOTE 1 – BUSINESS
Overview
EQUATOR Beverage Company, headquartered in Jersey City, NJ, is a Delaware corporation that specializes in developing, producing, distributing, and marketing new beverage products.
Our beverages have been certified Non-GMO Project Verified and USDA Organic, and we offer both nonalcoholic and ready-to-drink alcoholic options. In addition, we have a line of sparkling energy beverages targeted towards female consumers.
Our beverages can be found in North America, the Caribbean, and Bermuda. We are committed to sustainability and use 100% recyclable, eco-friendly packaging that has a minimal impact on the environment. Furthermore, our products are plant-based, renewable, and eco-friendly.
Coconut water is nature's super hydration drink for skin and body. In each 11 oz serving, there are five essential electrolytes totaling 1043 mg more than other sports drinks. It is a fast rehydration recovery drink which performs faster than water. Coconut water has natural nutrients for skin and hair and vitamins B & C natural - not added. Coconut water is plant based and renewable; great for vegan, kosher, paleo keto and low carb diets. All this comes with a fresh crisp coconut taste. There are no preservatives in this coconut water and it is packaged in an eco-friendly container.
CURRENT OPERATIONS
Sales and Distribution
The Company’s flagship product is MOJO Coconut Water. In addition to Coconut Water, the Company produces Coconut Water + Pineapple Juice, Organic Coconut Water, Sparkling Coconut Water Citrus, Sparkling Coconut Water Blood Orange, Sparkling Coconut Water Pink Grapefruit, Energy Sparkling Citrus, Energy Sparkling Blood Orange, Energy Sparkling Pink Grapefruit, Cubano Blue Agave Tequila Organic Sparkling Coconut Water Citrus and Cubano Blue Agave Tequila Organic Sparkling Coconut Water Blood Orange. We seek to grow the market share of our products by expanding our hybrid distribution network through the relationships and efforts of our management and third-party partners and broker network, and new products and packaging. The Company packages its beverages in 100% recyclable, Eco-Friendly packaging that can be recycled infinite times and is not made from carbon oil-based packaging. The packaging has a very low impact on the environment, and does not contribute to landfills and the pollution of our bodies of water. Also, our products are plant-based, Eco-friendly and renewable.
Production
The Company has multiple sources for its production. The Company’s fruit sources are of high quality. The fruit is part of the overall taste and quality of our products. Currently, the Company has multiple production facilities that it could source products from, each of the facilities could supply our forecasted demand.
Competition
The beverage industry is competitive. Competitors in our market compete for brand recognition, ingredient sourcing, product shelf space, and e-commerce page rankings. Our competitors have similar distribution channels and retailers to deliver and sell their products.
Government Regulation
Within the United States, beverages are governed by the U.S. Food and Drug Administration (the “FDA”). As such, it is necessary for the Company to establish, maintain and make available for inspection records as well as to develop labels (including nutrition information) that meet FDA requirements. The Company’s production facilities are subject to FDA regulation.
F-6
Table of Contents
Employees
As of September 30, 2023, the Company had two employees. The Company also uses the services of contractors, consultants and other third-parties. We contract with food brokers to represent our products to specific specialized sales channels. We utilize the services of direct sales and distribution companies that deliver and sell our products to their customers. We contract with manufacturing facilities to produce our products and outsource the storage and transportation of our products.
CORPORATE HISTORY AND DEVELOPMENT
The Company began producing MOJO branded products in 2016. EQUATOR Beverage Company is headquartered in Jersey City, New Jersey and our internet site is www.EquatorBeverage.com. EQUATOR’s stock is traded on the OTCQB under the symbol MOJO. On June 8, 2022, the Board of Directors and majority stockholder of the Company approved a change of name from MOJO Organics, Inc. to EQUATOR Beverage Company. This change of name was filed with the State of Delaware and became effective July 5, 2022.
Interim Financial Statements
The accompanying unaudited interim condensed financial statements have been prepared pursuant to the rules and regulations for reporting on Form 10-Q and article 10 of Regulation S-X and the related rules and regulations of the Securities and Exchange Commission (“SEC”). Accordingly, certain information and disclosures required by accounting principles generally accepted in the United States of America (“GAAP”) for complete financial statements have been condensed or omitted pursuant to such rules and regulations. However, the Company believes that the disclosures included in these financial statements are adequate to make the information presented not misleading. The unaudited interim condensed financial statements included in this document have been prepared on the same basis as the annual audited financial statements, and in the Company’s opinion, reflect all adjustments necessary for a fair presentation in accordance with GAAP and SEC regulations for interim financial statements. The results for the nine months ended September 30, 2023 are not necessarily indicative of the results that the Company will have for any subsequent period. These unaudited condensed financial statements should be read in conjunction with the audited financial statements and the notes to those statements for the year ended December 31, 2022 included in the Company’s Annual Report on Form 10-K.
NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Use of Estimates
The financial statements are prepared in conformity with accounting principles generally accepted in the United States (“GAAP”). Management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.
Cash and Cash Equivalents
Cash equivalents include investment instruments and time deposits purchased with a maturity of three months or less. As of September 30, 2023, and September 30, 2022, the Company did not have any cash equivalents.
Accounts Receivable
Accounts receivable is stated at the amount management expects to collect from outstanding balances. The Company provides for probable uncollectible amounts based upon its assessment of the current status of the individual receivables and after using reasonable collection efforts. The allowance for doubtful accounts as of September 30, 2023 and 2022 was zero.
F-7
Table of Contents
Inventory
Inventory, consisting solely of finished goods, are stated at the lower of cost (first-in, first-out method) or net realizable value (“NRV”). If necessary, the Company provides allowances to adjust the carrying value of its inventories to NRV when NRV is below cost. There were no such adjustments in 2023 or 2022.
Revenue Recognition
Revenue from sales of products is recognized when the related performance obligation is satisfied. The Company’s performance obligation is satisfied upon the shipment or delivery of products to customers. The Company’s products are sold on cash and credit terms which are established in accordance with standardized industry practices and typically require payment within 30 days of delivery.
Shipping and Handling Costs
Shipping and Handling Costs incurred to move finished goods from our distribution center to customer locations are included in the line Selling, General and Administrative Expenses in our Statements of Operations.
Net Income/(Loss) Per Common Share
The Company computes per share amounts in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 260, “ Earnings per Share”. ASC Topic 260 requires presentation of basic and diluted EPS. Basic EPS is computed by dividing the income/(loss) available to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted EPS is based on the weighted average number of shares of common stock and common stock equivalents outstanding during the periods.
Income Taxes
The Net Operating Loss Carryforward as of January 1, 2023 was $ 3,935,416 and $ 3,743,615 at January 1, 2022. The Taxable Income from January 1 to September 30, 2023 was $ 145,584 and the Net Operating Loss Carryforward as of September 30, 2023 was $ 3,789,832 . The Net Loss during the same period January 1 to September 30, 2022 was $ 7,882 , and the Net Operating Loss Carryforward as of September 30, 2022 was $ 3,751,497 .
The Federal Deferred Tax Asset on January 1, 2023 was $ 826,437 and the Federal Tax Expense as of September 30, 2023 was $ 30,573 . The Federal Deferred Tax Asset on January 1, 2022 was $ 786,159 and the Federal Tax Expense as of September 30, 2022 was $ 0 . The Federal Deferred Tax asset on September 30, 2023 was $ 795,865 and $ 786,159 on September 30, 2022. The Deferred Tax Asset for the State of New Jersey on January 1, 2023 was $ 354,187 and the State Income Tax Payable as of September 30, 2023 was $ 13,103 . The Deferred Tax Asset for the State of New Jersey on January 1, 2022 was $ 336,925 and the State Income Tax Payable was $ 0 . The Deferred Tax Asset for the State of New Jersey on September 30, 2023 was $ 341,085 and $ 336,925 on September 30, 2022. The Total Deferred Tax Assets as of September 30, 2023 is $ 1,136,950 and $ 1,123,084 as of September 30, 2022. The Deferred Tax assets have been fully reserved by valuation allowances beyond that portion which is expected to offset current taxes.
The Company provides for income taxes using the asset and liability approach in accounting for income taxes. Deferred tax assets and liabilities are recorded based on the differences between the financial statement and tax bases of assets and liabilities and the tax rates in effect when these differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance if, based on the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. The Company expects to utilize all Deferred Tax Assets. The Company did not have a deferred tax liability at September 30, 2023 and 2022.
F-8
Table of Contents
As of September 30, 2023, and September 30, 2022, the Company had no accrued interest or penalties. The Company had no Federal or State tax examinations in the past nor does it have any at the current time.
2023
2022
Net Operating Loss Carryforward, January 1
$ 3,395,416
$ 3,743,615
Taxable Income/ (Net Loss), January 1 to September 30
145,584
( 7,882 )
Net Operating Loss Carryforward, September 30
$ 3,789,832
$ 3,751,497
Federal Deferred Tax Asset, January 1
826,437
786,159
Federal Tax Expense as of September 30
30,573
-
Federal Deferred Tax Asset, September 30
$ 795,865
$ 786,159
State of New Jersey Deferred Tax Asset, January 1
354,187
336,925
State of New Jersey Tax Expense as of September 30
13,103
-
State of New Jersey Deferred Tax Asset, September 30
341,085
336,925
Total Deferred Tax Asset, September 30
$ 1,136,950
$ 1,123,084
Fair value of financial instruments
The carrying amounts of financial instruments, which include cash, accounts receivable, accounts payable and accrued expense, approximate their fair values due to their short-term nature.
NOTE 3 – COMMITMENTS AND CONTINGENCIES
Employment Agreement
Pursuant to Mr. Simpson’s Amended and Restated Employment Agreement (“the Agreement”) dated April 6, 2017 and amended on September 1, 2022, Mr. Simpson is paid a salary of $ 8,000 per month and a stock award of 67,000 shares of non-trading, restricted Common Stock. The employment agreement expires on March 31, 2027.
Pursuant to the Agreement, should Mr. Simpson’s employment be terminated without cause, the Company is obligated to pay Mr. Simpson all amounts from the contract immediately for the remaining term of 42 months. At September 30, 2023, the potential liability to EQUATOR Beverage Company was $ 336,000 and 2,814,000 shares of non-trading, restricted Common Stock.
NOTE 4 – STOCKHOLDERS’ EQUITY
On July 5, 2022, the State of Delaware approved the 1-for-2 reverse split and the decrease in Authorized shares from 40,000,000 to 20,000,000 shares.
On June 8, 2022, the Board of Directors of the Company approved a prospective amendment to the Fourth Article of the Company’s Articles of Incorporation to decrease the authorized common stock from 40,000,000 shares, par value $ 0.001 , to 20,000,000 shares, par value $ 0.001 . On June 8, 2022, the majority stockholders approved the decrease in authorized shares amendment by written consent, in lieu of a special meeting of the stockholders. On June 8, 2022, the Board of Directors of the Company approved the prospective amendment to the Company’s Articles of Incorporation to effect a 1-for-2 reverse split of the Company’s Common Stock . On June 8, 2022, stockholders of the Company owning a majority of the Company’s outstanding voting stock approved the reverse stock split by written consent, in lieu of a special meeting of the stockholders. The decrease in authorized shares and reverse stock split was approved by FINRA on July 19, 2022 and effective July 20, 2022. All share and per share data has been retroactively adjusted to reflect the reverse stock split.
F-9
Table of Contents
Restricted Stock Issuances
The table below summarizes the restricted stock awards during the first nine months of 2023 and 2022:
Restricted Stock Awards
Officers and Directors
January 1 to September 30
2023
2022
VWAP
Shares
Amount
VWAP
Shares
Amount
Q1
Q1
Glenn Simpson
0.06
201,000
$ 11,792
Glenn Simpson
0.20
450,500
$ 76,368
Diane Cudia
0.06
37,500
2,200
Diane Cudia
0.20
106,250
17,800
Jeffrey Devlin
0.06
37,500
2,200
Jeffrey Devlin
0.20
106,250
17,800
Total
276,000
16,192
Total
663,000
111,968
Q2
Q2
Glenn Simpson
0.10
201,000
22,110
Glenn Simpson
0.16
100,500
17,554
Diane Cudia
0.10
37,500
4,125
Diane Cudia
0.16
18,750
3,275
Jeffrey Devlin
0.10
37,500
4,125
Jeffrey Devlin
0.16
18,750
3,275
Total
276,000
30,360
Total
138,000
24,104
Q3
Q3
Glenn Simpson
0.45
201,000
94,403
Glenn Simpson
0.12
201,000
20,100
Jeffrey Devlin
0.45
37,500
17,613
Jeffrey Devlin
0.12
37,500
3,750
Total
238,500
112,016
Total
238,500
23,850
Grand Total
790,500
$ 158,568
Grand Total
1,039,500
$ 159,922
On June 1, 2022, Mr. Simpson exercised his options to purchase 159,054 shares of Restricted and Non-Trading shares at $ 0.16 per share. The total purchase price was $ 24,449 . The stock closed at $ 0.16 on the exercise date. There were no options outstanding after this option exercise.
Stock Purchased for Cancellation
During the nine months ended September 30, 2023, the Company purchased 380,019 shares of its Restricted Common Stock from shareholders at a cost of $ 38,002 .
During the year ended December 31, 2022 the Company purchased 830,342 shares of its Restricted Common Stock from shareholders at a cost of $ 193,188 .
NOTE 5 – STOCK OPTIONS
As of September 30, 2023, there are no outstanding stock options and there was no obligation to issue stock options.
On June 1, 2022, Mr. Simpson exercised options to purchase 159,054 shares of Restricted and Non-Trading shares at $ 0.16 per share.
The total purchase price was $ 25,449 . The stock closed at $ 0.16 on the exercise date. There were no options outstanding after this option exercise.
On February 4, 2022, the Company adjusted the exercise price of the options granted to Mr. Simpson from $ 0.32 per share to $ 0.16 per share. The stock closed at $ 0.17 on that day.
During the nine months ended September 30, 2023 and 2022, compensation expense related to stock options was $ 0 . As of September 30, 2023, there was no unrecognized compensation cost related to non-vested stock options.
NOTE 6 – RELATED PARTY TRANSACTIONS
Mr. Simpson lent funds to the Company for a revolving loan with a principal amount up to $ 300,000 . The loan bears a 6 % simple interest per year. The principal and any accrued interest are due and payable on demand, and the Company has the right to pay back the loan in full or make payments without penalty.
As of September 30, 2023, the loan payable to Mr. Simpson was $ 240,000 .
As of September 30, 2022, the loan payable to Mr. Simpson was $ 275,000 .
On June 1, 2022, Mr. Simpson exercised 159,054 stock options at an exercise price of $ 0.16 . The Company issued 159,054 Restricted and Non-Trading shares of Common Stock in exchange for the total purchase price of $ 25,449 . The stock closed at $ 0.16 on the exercise date. There were no options outstanding after this option exercise.
F-10
Table of Contents
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.